RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (RIGL)

CUSIP: 766559702

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
18,617,462
Total 13F shares
13,883,445
Share change
+8,178
Total reported value
$260,032,689
Put/Call ratio
0%
Price per share
$18.73
Number of holders
121
Value change
+$336,299
Number of buys
60
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 766559702?
CUSIP 766559702 identifies RIGL - RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RIGL - RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F 13D/G
Company
7.7%
from 13D/G
1,732,604
$31,169,546 31 Mar 2025
ARMISTICE CAPITAL, LLC
13D/G 13F
Company
8.5%
1,516,000
$28,894,960 +$6,937,840 31 Mar 2025
MORGAN STANLEY
13F
Company
8.3%
1,536,987
$27,650,397 31 Mar 2025
13F
Soleus Capital Management, L.P.
13F
Company
6.1%
1,130,679
$20,340,915 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
5.5%
1,028,072
$18,495,015 31 Mar 2025
13F
Capitolis Liquid Global Markets LLC
13F
Company
3.7%
693,100
$12,468,869 31 Mar 2025
13F
STATE STREET CORP
13F
Company
3.4%
637,034
$11,460,242 31 Mar 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
3%
565,045
$10,161,000 31 Mar 2025
13F
Assenagon Asset Management S.A.
13F
Company
2.8%
522,781
$9,404,830 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.2%
411,168
$7,398,878 31 Mar 2025
13F
CM Management, LLC
13F
Company
1.3%
250,000
$4,497,500 31 Mar 2025
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
1.2%
217,776
$3,917,790 31 Mar 2025
13F
MARSHALL WACE, LLP
13F
Company
1.1%
211,748
$3,809,347 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.1%
201,146
$3,618,617 31 Mar 2025
13F
Hillsdale Investment Management Inc.
13F
Company
1%
192,164
$3,457,031 31 Mar 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.85%
157,924
$2,841,053 31 Mar 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.83%
154,617
$2,781,560 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.77%
142,459
$2,562,838 31 Mar 2025
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0.72%
134,363
$2,417,000 31 Mar 2025
13F
Invesco Ltd.
13F 13D/G
Company
0.03%
from 13D/G
134,072
$2,411,955 31 Mar 2025
BANK OF AMERICA CORP /DE/
13F
Company
0.71%
132,437
$2,382,541 31 Mar 2025
13F
ZACKS INVESTMENT MANAGEMENT
13F
Company
0.69%
128,088
$2,304,302 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.62%
115,218
$2,072,771 31 Mar 2025
13F
Pacer Advisors, Inc.
13F
Company
0.6%
112,629
$2,026,196 31 Mar 2025
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.59%
110,384
$1,985,808 31 Mar 2025
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.56%
104,455
$1,879,145 31 Mar 2025
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.46%
86,176
$1,550,307 31 Mar 2025
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.42%
77,570
$1,395,484 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.36%
66,337
$1,193,403 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.35%
65,300
$1,174,747 31 Mar 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.33%
61,398
$1,104,550 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.32%
59,474
$1,069,938 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.3%
55,427
$997,132 31 Mar 2025
13F
GLOBEFLEX CAPITAL L P
13F
Company
0.28%
52,295
$940,787 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.27%
49,572
$891,801 31 Mar 2025
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.26%
48,874
$879,243 31 Mar 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.25%
47,470
$853,985 31 Mar 2025
13F
UBS Group AG
13F
Company
0.25%
46,715
$840,403 31 Mar 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.24%
44,686
$804,000 31 Mar 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.23%
41,928
$754,285 31 Mar 2025
13F
Jackson Creek Investment Advisors LLC
13F
Company
0.2%
38,045
$684,000 31 Mar 2025
13F
SEGALL BRYANT & HAMILL, LLC
13F
Company
0.19%
36,001
$647,658 31 Mar 2025
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.18%
33,369
$600,308 31 Mar 2025
13F
Trexquant Investment LP
13F
Company
0.18%
33,101
$595,487 31 Mar 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.17%
31,473
$566,199 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.17%
30,953
$556,844 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.17%
30,851
$555,009 31 Mar 2025
13F
CITIGROUP INC
13F
Company
0.16%
30,172
$542,794 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0.16%
29,211
$525,506 31 Mar 2025
13F
Dynamic Technology Lab Private Ltd
13F
Company
0.15%
27,117
$488,000 31 Mar 2025
13F

Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (RIGL) as of Q2 2025

As of 30 Jun 2025, RIGEL PHARMACEUTICALS INC - Common Stock, $0.001 par value per share (RIGL) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,883,445 shares. The largest 10 holders included BlackRock, Inc., ARMISTICE CAPITAL, LLC, MORGAN STANLEY, VANGUARD GROUP INC, Soleus Capital Management, L.P., ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, Capitolis Liquid Global Markets LLC, GEODE CAPITAL MANAGEMENT, LLC, and MARSHALL WACE, LLP. This page lists 121 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
118
Q2 2025 holders
121
Holder diff
3
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .